When will Souvenaid become available in Canada and US to treat Alzheimer’s Disease?

When will Souvenaid become available in Canada and US to treat Alzheimer's Disease? by Connie b. Dellobuono

Answer by Connie b. Dellobuono:

You do not have to wait as you can study the nutrients in Souvenaid and find them in the USA. Souvenaid nutrients aim to extend the life of synapses in the brain. But recent studies related to the multifactorial causes of Alzheimer's point to gut bacteria (can be balanced by acidophilus and pickled veggies, avoiding sugar, more on whole foods), diabetes, depression, stress, toxins, lack of sleep and exercise and use of some medications (OTC and prescribed such as narcotics).
From Wiki:
Souvenaid is a medical nutrition formulation, presented as a drink, that has been studied for potential use in the dietary management of early Alzheimer's disease.A NPS MedicineWise summary stated (based on three randomized controlled trials) that Souvenaid failed to show a significant effect in decreasing the rate of cognitive decline or delaying progression of Alzheimer's disease, but that there may be a minor improvement in memory in drug naive people in the very early stages of the disease.
Souvenaid was developed by Advanced Medical Nutrition division of Nutricia and contains a patented combination of nutrients, referred to under the trademark Fortasyn Connect.
Composition
The composition of Souvenaid includes:
Eicosapentaenoic acid, 300 mg
Docosahexaenoic acid, 1200 mg
Phospholipids, 106 mg
Choline, 400 mg
Uridine monophosphate, 625 mg
Vitamin E (alpha-tocopherol equivalents), 40 mg
Selenium, 60 µg
Vitamin B12, 3 µg
Vitamin B6, 1 mg
Folic acid, 400 µg
Vitamin C, 80 mg

When will Souvenaid become available in Canada and US to treat Alzheimer's Disease?

Leave a Reply